Doha, 11 October 2025: Hamad Medical Corporation (HMC) has signed a Memorandum of Understanding (MoU) with AbbVie Biopharmaceuticals Gulf Levant to bring the Clinical Research Advancement Integrated Signature Program (CRISP) to HMC. The program is designed to give clinical research professionals access to world-class training, internationally recognized certification, and ongoing professional support.
AbbVie, in partnership with the Association of Clinical Research Professionals (ACRP), the only non-profit dedicated exclusively to supporting clinical research professionals globally—will offer a structured learning program for HMC’s researchers and healthcare staff. Through this collaboration, participants will benefit from a structured learning pathway and also have the opportunity to earn ACRP certifications.
Training will cover areas such as good clinical practice, patient safety, research ethics, protocol design, inspection readiness, and the use of new models. By adopting CRISP, HMC aims to further strengthen the quality and impact of its clinical research, supporting safer, more effective treatments and better outcomes for patients.
The partnership with AbbVie marks an important step to advance clinical research in HMC. By providing clinical research professionals with access to internationally recognized training and certification, HMC seeks to build stronger research capacity and ensure its work meets the highest global standards. Ultimately, this will benefit patients and help position Qatar as a leader in medical innovation.”
AbbVie Biopharmaceuticals Gulf Levant highlighted the importance of this transformative partnership with Hamad Medical Corporation, underscoring the shared commitment of both parties to excellence in clinical research across HMC and Qatar. CRISP will help set new benchmarks in education, certification, and patient safety—empowering clinical research professionals to advance healthcare outcomes and raise the standards of care at HMC and beyond.”
Since its launch, CRISP has grown rapidly across the region, with more than 700 certificates awarded to participants from over 15 countries. It has also been accredited by major health authorities, underlining its value as a proven model for advancing healthcare research and education.
